Adaptive Biotechnologies (ADPT): Can Blood Cancer Guidelines Boost Repeat Testing?
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) highlighted updated National Comprehensive Cancer Network, or NCCN, multiple myeloma guidelines on September 17.
Adaptive Biotechnologies Corp (ADPT)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Viking Global Andreas Halvorsen | 7,498,427 | $643,365,037 | 1.83% | |
| 2. | D E Shaw D. E. Shaw | 1,156,464.75 | $99,224,675 | +136% | 0.05% |
| 3. | Driehaus Capital Richard Driehaus | 631,925.75 | $54,219,229 | +45% | 0.31% |
| 4. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 631,155 | $54,153,099 | +27% | 0.02% |
| 5. | ARK Investment Management Catherine D. Wood | 522,576.5 | $44,837,058 | -1% | 0.29% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $20.00 | 2,500 | $50,000.00 | 2,500 | 2019-07-01 | Filing | |
| $20.00 | 1,000 | $20,000.00 | 1,000 | 2019-07-01 | Filing | |
| $20.00 | 300 | $6,000.00 | 300 | 2019-07-01 | Filing | |
| $20.00 | 400 | $8,000.00 | 400 | 2019-07-01 | Filing | |
| $20.00 | 500 | $10,000.00 | 500 | 2019-07-01 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $28.57 | 7,869 | $224,817.33 | 220,867 | 2026-09-16 | Filing | |
| $28.02 | 107,537 | $3,013,186.74 | 228,736 | 2026-09-16 | Filing | |
| $27.00 | 1,195 | $32,265.00 | 395,794 | 2026-09-15 | Filing | |
| $26.00 | 9,615 | $249,990.00 | 78,639 | 2026-08-26 | Filing | |
| $24.41 | 15,664 | $382,358.24 | 46,683 | 2026-08-18 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 3,784,789.75 | $324,734,962 | 0% | |
| 2. | 1,600,896.75 | $137,356,941 | 0% | |
| 3. | 1,477,841.5 | $126,798,802 | 0.02% | |
| 4. | 1,369,057.75 | $117,465,155 | 0.01% | |
| 5. | 1,066,911.25 | $91,540,985 | 0.3% |
News See All
10 Best Growth Stocks to Buy and Hold for the Next Decade
In this article, we will look at the 10 Best Growth Stocks to Buy and Hold for the Next Decade.
10 Best Growth Stocks Under $20 to Buy
In this article, we will discuss the 10 Best Growth Stocks Under $20 to Buy.
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q1 2026 Earnings Call Transcript
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q1 2026 Earnings Call Transcript May 5, 2026Adaptive Biotechnologies Corporation beats earnings expectations.
Why are Analysts Optimistic About Adaptive Biotechnologies (ADPT)?
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) is one of the best hot stocks under $20 to buy.
10 Hot Stocks Under $20 to Buy
In this article, we will look at the 10 Hot Stocks Under $20 to Buy.
TD Cowen is Bullish on Adaptive Biotechnologies Corporation (ADPT)
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) is among the Most Volatile Stocks.
11 Most Volatile Stocks to Buy According to Hedge Funds
In this article, we will discuss: 11 Most Volatile Stocks to Buy According to Hedge Funds.
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q4 2025 Earnings Call Transcript
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q4 2025 Earnings Call Transcript February 5, 2026Adaptive Biotechnologies Corporation beats earnings expectations.
Adaptive Biotechnologies (ADPT) Falls 24.5% as Execs Dispose Millions of Stake
We recently published December Disappointments: 10 Big Names Troubled Early. Adaptive Biotechnologies Corp. (NASDAQ:ADPT) is one of the worst performers of last week.
Hedge Fund Resource Center